VAERS reports by lot

GSK Hepatitis A lot F73DG: VAERS reports

20 VAERS reports list lot F73DG as a GSK Hepatitis A vaccine, received between 2022-01-15 and 2023-10-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological725%
Dermatological (non-injection-site)518%
Cardiac / Cardiovascular414%
General / Systemic (non-local)414%
Injection-site / Local reaction311%
Gastrointestinal27%
Musculoskeletal27%
Allergic / Anaphylactic14%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois3
Texas2
Florida2
Maine2
California2
Georgia1
Hawaii1
Tennessee1
Massachusetts1
Pennsylvania1
Arkansas1
North Carolina1

Reports by month received

2022-011
2022-042
2022-052
2022-061
2022-071
2022-092
2022-101
2023-021
2023-052
2023-073
2023-083
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.